Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.65M P/E 0.01 EPS this Y 53.30% Ern Qtrly Grth -
Income -22.53M Forward P/E -0.67 EPS next Y 94.90% 50D Avg Chg -21.00%
Sales 1.36M PEG - EPS past 5Y - 200D Avg Chg -86.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -99.00%
Recommedations 2.00 Quick Ratio 0.28 Shares Outstanding 554.88K 52W Low Chg 92.00%
Insider Own 0.32% ROA -64.75% Shares Float 497.38K Beta 1.47
Inst Own 7.34% ROE - Shares Shorted/Prior 88.06K/14.29K Price 2.98
Gross Margin -105.52% Profit Margin - Avg. Volume 2,137,636 Target Price 24.00
Oper. Margin -3,011.70% Earnings Date Mar 14 Volume 210,482 Change -1.47%
About Baudax Bio, Inc.

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Baudax Bio, Inc. News
01/24/23 Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
12/08/22 Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
12/06/22 Baudax Bio Announces Closing of $5 Million Public Offering
12/02/22 Baudax Bio Announces Pricing of $5 Million Public Offering
04:50 PM Baudax Bio Announces 1-for-40 Reverse Stock Split
11/08/22 Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights
09/19/22 Baudax Bio Announces Distribution of Series B Preferred Stock to Holders of its Common Stock
09/08/22 Baudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare Conference
09/01/22 Baudax Bio Announces Closing of $6.2 Million Public Offering
08/29/22 Baudax Bio Announces Pricing of $6.2 Million Public Offering
08/22/22 Baudax Bio receives notice of allowance for U.S. Patent Application covering use of ANJESO® for the treatment of moderate to severe pain
08/11/22 Baudax Bio Reports Second Quarter 2022 Financial Results and Business Highlights
06/01/22 Baudax Bio Announces Dosing of First Cohort in First-in-Man, Phase I Clinical Study Evaluating BX2000
05/18/22 Baudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference
05/17/22 Baudax Bio Announces $2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
05/05/22 Baudax Bio Announces Date of Reconvened Annual Meeting of Shareholders
05/04/22 Baudax Bio Reports First Quarter 2022 Financial Results and Business Highlights
05/02/22 Baudax Bio to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 5, 2022
04/13/22 Baudax Bio to Present at NobleCon18 Investor Conference
04/11/22 What Makes Baudax Bio, Inc. (BXRX) a New Strong Buy Stock
BXRX Chatroom

User Image zeflash Posted - 52 minutes from now

$BXRX red to green;-)

User Image BufordJuztice Posted - 11 minutes from now

$BXRX ceo should tweet about fighting the naked shorts. This microfloat could easily see double digits if volume pours in strong

User Image Elisio Posted - 18 minutes ago

MM There is no problem to print more and more shares to lower it, where there is no supervision the scams thrive 🤢🤮 $INPX $PBLA $KERN $BXRX

User Image BufordJuztice Posted - 23 minutes ago

$BXRX scaled some in at 2.85, I like it for a swing at these levels

User Image mrshort Posted - 54 minutes ago

$BXRX Estimated S.I as on 1/27/22 17.96 Percent Please complete information please join me via stocktwits.com/mrshort, for stock alerts, news, chat rooms, squeeze ranking watchlist. We are consistency hitting profit with our trading strategy. CAKE has Institutional ownership of 89.57% and inside ownership of 7.23% Analyst rating 3.13 and Long Term Debt/ Capital 39.70% Our members daily updated information of highly shorted stock, squeeze ranking, access to Chat rooms, IPO analysis, Daily watchlist, Market Watchlist.Catalyst.

User Image RedRover Posted - 1 hour ago

$BXRX What happened to all the pumpers?

User Image BB_88_ Posted - 1 hour ago

$bxrx 2.7 dip and rise

User Image RedRover Posted - 1 hour ago

$BXRX Note to SEC: Baudax Bio CEO Gerri Henwood saw her base pay double from 2020 to 2021 to over $600,000. When do we find out how much she was paid in 2022? What's her salary this year. This is a public company. Why aren't these numbers public? Late stage capitalism in action.

User Image Huskersnsaints Posted - 1 hour ago

$BXRX 50 million shares in one day on a 500k float and now this stock is just getting crushed on a tiny volume!!!! CROOKS DESTROYING STOCKS JUST BECAUSE THEY CAN

User Image mat81bo Posted - 1 hour ago

$BXRX but how many rs has he made since 2020? it was worth 11500 dollars!!!

User Image longtermopportunity Posted - 2 hours ago

$BXRX waiting for re-entry once buying picks up

User Image dividendinvestorbyeagle Posted - 3 hours ago

$BXRX close decreased > 10% (Baudax Bio Inc) https://www.dividendinvestor.com/dividend-news/?symbol=bxrx

User Image mat81bo Posted - 4 hours ago

$BXRX bye bye 3$

User Image Caglebass Posted - 14 hours ago

$NURO $BXRX $CFRX ….. check out super low float OTC ticker $ACGX …. This one has been flying under the radar & has big merger news coming any day now!! 🚨🚨💵💵💰💰🚀🚀. $ACGX

User Image stockilluminati Posted - 15 hours ago

$BXRX https://www.stockilluminati.com/#watchlist lost -7 watchers today! - Check https://www.stockilluminati.com/bxrx/miscellaneous.php for trend data

User Image ChartMill Posted - 1 day ago

$BXRX was analyzed by 7 analysts. The buy consensus is at 83%. So analysts seem to be very confident about $BXRX. https://www.chartmill.com/stock/quote/BXRX/analyst-ratings?utm_source=stocktwits&utm_medium=ANALYST&utm_content=BXRX&utm_campaign=social_tracking

User Image TomMac64 Posted - 1 day ago

$BXRX what science ?

User Image WallStreetBuyDip Posted - 2 days ago

$BXRX I'll buy when its algos hit "5% heaviness" for the day like I did for MULN This shows those plays with showing STEP BY STEP on how I did it with timestamps. The KEY is to buy when Algos hit "5% HEAVINESS" Learn what "5% HEAVINESS" means by Algos. Look at the: 1) Time I alerted. 2) $ level 3) Heaviness % by Algos

User Image CrytiCaII Posted - 2 days ago

$BXRX what a massive run into the open and the 6.60 level. Could not hold up intraday though and closed the week red. Ran +67.0% after we mentioned it ✅

User Image ChartMill Posted - 2 days ago

$BXRX: The Revenue is expected to grow by 46.16% on average over the next 5 years. This is a very strong growth https://www.chartmill.com/stock/quote/BXRX/fundamental-analysis?key=d6764428-a425-4c02-accf-b432e734720a&utm_source=stocktwits&utm_medium=FA&utm_content=BXRX&utm_campaign=social_tracking

User Image shortvolumes Posted - 2 days ago

2023-01-27 Short sale volume (not short interest) for $BXRX is 39%. http://shortvolumes.com/?t=BXRX via @shortvolumes

User Image DotcomBull Posted - 2 days ago

$INPX this, $XELA , $BXRX $TNXP best pos on Nasdaq

User Image Chris_717 Posted - 2 days ago

$BXRX I think there may be a sale of Anjeso in the works. FDA approved drug.

User Image mat81bo Posted - 2 days ago


User Image Goobered66 Posted - 2 days ago

$AKAN Add this to the garbage heap of failed pumps this week, just like these turds $ENSC $TCBP $BXRX

User Image RedRover Posted - 2 days ago

$BXRX knowing Gerri, she will announce the next dilution on a Friday after the bell. Could very well be today.

User Image tickeron Posted - 3 days ago

Buy or sell now, what do you think? $BXRX enters a Downtrend because Momentum Indicator dropped below the 0 level on January 25, 2023. View odds for this and other indicators: https://srnk.us/go/4352654

User Image BB_88_ Posted - 3 days ago

$BXRX nice technical bounce

User Image Goobered66 Posted - 3 days ago

$TCBP This reminds me of the other 2 failed pumps this week $BXRX $ERNC

User Image BLUE_market Posted - 3 days ago

$BXRX Science in the long run always pays

Analyst Ratings
Oppenheimer Outperform May 11, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HENWOOD GERALDINE President and CEO President and CEO Dec 15 Buy 2.5476 1,200 3,057 2,427 12/19/22